{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:38:04Z","timestamp":1772843884014,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T00:00:00Z","timestamp":1554595200000},"content-version":"am","delay-in-days":249,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030 149954"],"award-info":[{"award-number":["310030 149954"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.tiv.2018.03.016","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T12:39:01Z","timestamp":1522499941000},"page":"242-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis"],"prefix":"10.1016","volume":"50","author":[{"given":"Friederike A.","family":"Sandbaumh\u00fcter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vimercati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Thormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-9556","authenticated-orcid":false,"given":"Meike","family":"Mevissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2018.03.016_bb0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2460\/ajvr.70.6.777","article-title":"In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs","volume":"70","author":"Capponi","year":"2009","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tiv.2018.03.016_bb0010","series-title":"Equine Pharmacology","first-page":"44","article-title":"Anesthesia and sedation in the field","author":"Carter","year":"2014"},{"key":"10.1016\/j.tiv.2018.03.016_bb0015","series-title":"Human Drug Metabolism, in Introduction","author":"Coleman","year":"2010"},{"key":"10.1016\/j.tiv.2018.03.016_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0007-1935(96)80005-4","article-title":"Medetomidine sedation in dogs and cats: a review of its pharmacology, antagonism and dose","volume":"152","author":"Cullen","year":"1996","journal-title":"Br. Vet. J."},{"key":"10.1016\/j.tiv.2018.03.016_bb0025","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/00498254.2012.685777","article-title":"Stereoselective and regiospecific hydroxylation of ketamine and norketamine","volume":"42","author":"Desta","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2018.03.016_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth. Prog."},{"key":"10.1016\/j.tiv.2018.03.016_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1467-2995.2011.00669.x","article-title":"Pharmacokinetics and pharmacodynamics of intravenous medetomidine in the horse","volume":"39","author":"Grimsrud","year":"2012","journal-title":"Vet. Anaesth. Anal."},{"key":"10.1016\/j.tiv.2018.03.016_bb0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1124\/dmd.30.7.853","article-title":"Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes","volume":"30","author":"Hijazi","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2018.03.016_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cpdd.326","article-title":"Current concepts in methadone metabolism and transport","volume":"6","author":"Kharasch","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.tiv.2018.03.016_bb0050","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/00000542-199212000-00023","article-title":"Ketamine as a probe for medetomidine stereoisomer inhibition of human liver microsomal drug metabolism","volume":"77","author":"Kharasch","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tiv.2018.03.016_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.taap.2006.06.011","article-title":"Actinociceptive effects metabolism and disposition of ketamine in ponies under target-controlled drug infusion","volume":"216","author":"Knobloch","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2018.03.016_bb0060","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1124\/dmd.110.032953","article-title":"Molecular cloning, functional expression and initial characterization of members of the CYP3A family in horses","volume":"38","author":"Knych","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2018.03.016_bb0065","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/elps.201100095","article-title":"Enantioselective capillary electrophoresis for the assessment of CYP3A4-mediated ketamine demethylation and inhibition in vitro","volume":"32","author":"Kwan","year":"2011","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tiv.2018.03.016_bb0070","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bja\/ael336","article-title":"Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies","volume":"98","author":"Larenza","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.tiv.2018.03.016_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2460\/ajvr.73.2.290","article-title":"Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses","volume":"73","author":"Linardi","year":"2012","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tiv.2018.03.016_bb0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/cns.12099","article-title":"Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)","volume":"19","author":"Mion","year":"2003","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0085","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.talanta.2010.08.005","article-title":"A parallel chiral-achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome","volume":"82","author":"Moaddel","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.tiv.2018.03.016_bb0090","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2460\/ajvr.72.11.1505","article-title":"Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs and humans","volume":"72","author":"M\u00f6ssner","year":"2011","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tiv.2018.03.016_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jvp.12303","article-title":"Characterization of equine cytochrome P450: role of CYP3A in the metabolism of diazepam","volume":"39","author":"Nakayama","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0100","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","article-title":"The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties","volume":"239","author":"Omura","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2018.03.016_bb0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/cns.12111","article-title":"Ketamine in Pain Management","volume":"19","author":"Persson","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.taap.2012.10.028","article-title":"Equine cytochrome P450 2B6\u2014genomic identification, expression and functional characterization with ketamine","volume":"266","author":"Peters","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2018.03.016_bb0115","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1016\/j.chroma.2010.06.028","article-title":"Enantioselective capillary electrophoresis for identification and characterization of human cytochrome P450 enzymes which metabolize ketamine and norketamine in vitro","volume":"1217","author":"Portmann","year":"2010","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tiv.2018.03.016_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0019-5049.130813","article-title":"Dexmedetomidine decreases the requirement of ketamine and propofol during burns debridement and dressings","volume":"58","author":"Ravipati","year":"2014","journal-title":"Indian J. Anaesth."},{"key":"10.1016\/j.tiv.2018.03.016_bb0125","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1002\/elps.201500147","article-title":"Effects of medetomidine and its active enantiomer dexmedetomidine on N-demethylation of ketamine in canines determined in vitro using enantioselective capillary electrophoresis","volume":"36","author":"Sandbaumh\u00fcter","year":"2015","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tiv.2018.03.016_bb0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chroma.2016.07.060","article-title":"Pharmacokinetics of ketamine and three metabolites in beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis","volume":"1467","author":"Sandbaumh\u00fcter","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.tiv.2018.03.016_bb0135","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/elps.201700017","article-title":"Effect of the \u03b12-receptor agonists medetomidine, detomidine, xylazine and romifidine on the ketamine metabolism in equines assessed with enantioselective capillary electrophoresis","volume":"38","author":"Sandbaumh\u00fcter","year":"2017","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tiv.2018.03.016_bb0140","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2885.2008.00972.x","article-title":"Stereoselective biotransformation of ketamine in equine liver and lung microsomes","volume":"31","author":"Schmitz","year":"2008","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0145","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/elps.200900221","article-title":"CE provides evidence of the stereoselective hydroxylation of norketamine in equines","volume":"30","author":"Schmitz","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tiv.2018.03.016_bb0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2052.2010.02111.x","article-title":"Comparative human-horse sequence analysis of CYP3A subfamily gene cluster","volume":"41","author":"Schmitz","year":"2010","journal-title":"Anim. Genet."},{"key":"10.1016\/j.tiv.2018.03.016_bb0155","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/elps.200900703","article-title":"Enantioselective CE analysis of hepatic ketamine metabolism in different species in vitro","volume":"31","author":"Schmitz","year":"2010","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tiv.2018.03.016_bb0160","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jvp.12106","article-title":"In vitro metabolism of testosterone in the horse liver and involvement of equine CYPs 3A89, 3A94 and 3A95","volume":"37","author":"Schmitz","year":"2014","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3565(25)27131-2","article-title":"Metabolism of diazepam in rat, dog and man","volume":"149","author":"Schwartz","year":"1965","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0737-0806(00)70457-6","article-title":"A review of diazepam and its use in the horse","volume":"20","author":"Shini","year":"2000","journal-title":"Equine Vet. J."},{"key":"10.1016\/j.tiv.2018.03.016_bb0175","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/elps.201500468","article-title":"Microassay for ketamine and metabolites in plasma and serum based on enantioselective capillary electrophoresis with highly sulfated \u03b3-cyclodextrin and electrokinetic analyte injection","volume":"37","author":"Theurillat","year":"2016","journal-title":"Electrophoresis"},{"key":"10.1016\/j.tiv.2018.03.016_bb0180","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2885.2012.01379.x","article-title":"Differential gene expression of CYP3A isoforms in equine liver and intestines","volume":"35","author":"Tyd\u00e9n","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2018.03.016_bb0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tiv.2017.02.017","article-title":"Testosterone metabolism of equine single CYPs of the 3A subfamily compared to the human CYP3A4","volume":"41","author":"Vimercati","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2018.03.016_bb0190","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra032424","article-title":"Drug metabolism and variability among patients in drug response","volume":"352","author":"Wilkinson","year":"2005","journal-title":"N. Engl. J. Med."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723331830119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723331830119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:30:34Z","timestamp":1760135434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723331830119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":38,"alternative-id":["S088723331830119X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2018.03.016","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of the equine CYP3A94, CYP3A95 and CYP3A97 in ketamine metabolism in presence of medetomidine, diazepam and methadone studied by enantioselective capillary electrophoresis","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2018.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}